(S)-Methyl 2-(4-Amino-3-((S)-2-amino-5-guanidinopentanamido)benzamido)-3-(4-hydroxyphenyl)-propanoate

ID: ALA3416696

Chembl Id: CHEMBL3416696

PubChem CID: 118734263

Max Phase: Preclinical

Molecular Formula: C23H31N7O5

Molecular Weight: 485.55

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1ccc(N)c(NC(=O)[C@@H](N)CCCNC(=N)N)c1

Standard InChI:  InChI=1S/C23H31N7O5/c1-35-22(34)19(11-13-4-7-15(31)8-5-13)30-20(32)14-6-9-16(24)18(12-14)29-21(33)17(25)3-2-10-28-23(26)27/h4-9,12,17,19,31H,2-3,10-11,24-25H2,1H3,(H,29,33)(H,30,32)(H4,26,27,28)/t17-,19-/m0/s1

Standard InChI Key:  JECKMXQKZJERLG-HKUYNNGSSA-N

Alternative Forms

  1. Parent:

    ALA3416696

    ---

Associated Targets(Human)

ERAP1 Tchem Endoplasmic reticulum aminopeptidase 1 (581 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERAP2 Tchem Endoplasmic reticulum aminopeptidase 2 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNPEP Tchem Cystinyl aminopeptidase (313 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Erap1 Endoplasmic reticulum aminopeptidase 1 (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 485.55Molecular Weight (Monoisotopic): 485.2387AlogP: 0.02#Rotatable Bonds: 11
Polar Surface Area: 218.67Molecular Species: BASEHBA: 8HBD: 8
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 11#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.50CX Basic pKa: 12.01CX LogP: -0.67CX LogD: -3.02
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.07Np Likeness Score: -0.07

References

1. Papakyriakou A, Zervoudi E, Tsoukalidou S, Mauvais FX, Sfyroera G, Mastellos DC, van Endert P, Theodorakis EA, Vourloumis D, Stratikos E..  (2015)  3,4-diaminobenzoic acid derivatives as inhibitors of the oxytocinase subfamily of M1 aminopeptidases with immune-regulating properties.,  58  (3): [PMID:25635706] [10.1021/jm501867s]
2. Mpakali A, Giastas P, Deprez-Poulain R, Papakyriakou A, Koumantou D, Gealageas R, Tsoukalidou S, Vourloumis D, Mavridis IM, Stratikos E, Saridakis E..  (2017)  Crystal Structures of ERAP2 Complexed with Inhibitors Reveal Pharmacophore Requirements for Optimizing Inhibitor Potency.,  (3): [PMID:28337326] [10.1021/acsmedchemlett.6b00505]

Source